Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. - Wikidata - wikimedia - TriplyDB

Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention.

Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention.

http://www.wikidata.org/entity/Q33792231

about

Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry Metabolic reprogramming and metabolic dependency in T cells The role of EMMPRIN in T cell biology and immunological diseases The roles of CD147 and/or cyclophilin A in kidney diseases Lung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromium VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice Involvement of HAb18G/CD147 in T cell activation and immunological synapse formation.Extracellular cyclophilin levels associate with parameters of asthma in phenotypic clusters Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A A new approach for analyzing cellular infiltration during allergic airway inflammation The level of CD147 expression correlates with cyclophilin-induced signalling and chemotaxis.A cyclosporin derivative discriminates between extracellular and intracellular cyclophilins Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A A miRNA-492 binding-site polymorphism in BSG (basigin) confers risk to psoriasis in central south Chinese population.IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro.Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9.Cyclophilin A (CyPA) induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147 Cyclophilin A is associated with peripheral artery disease and chronic kidney disease in geriatrics: The Tianliao Old People (TOP) study Cyclophilin A cooperates with MIP-2 to augment neutrophil migration Blocking cyclophilins in the chronic phase of asthma reduces the persistence of leukocytes and disease reactivation.Exposure to particulate hexavalent chromium exacerbates allergic asthma pathology.Extracellular cyclophilin A possesses chemotaxic activity in cattle.Local blockage of EMMPRIN impedes pressure ulcers healing in a rat model.Association Study between an SNP in CD147 and Its Expression With Acute Coronary Syndrome in a Jiangsu Chinese Population CD147 immunoglobulin superfamily receptor function and role in pathology Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure Targeting extracellular cyclophilins ameliorates disease progression in experimental biliary atresia.EMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction.Functional analysis of Leishmania major cyclophilin A cell-impermeable cyclosporine A derivative reduces pathology in a mouse model of allergic lung inflammation.The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion Expression and prognostic relevance of cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma.Cyclophilin A: a key player for human disease Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.Basigin: a multifunctional membrane protein with an emerging role in infections by malaria parasites.Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases.Tracking and treating activated T cells.CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint.Extracellular cyclophilins in health and disease.Upregulation of EMMPRIN after permanent focal cerebral ischemia.

P2860

Q24612679-485CCD5E-0183-4FBD-8C77-83F7AF5221B8 Q26864319-504C2752-6637-46AE-87AE-8B2F4430FBE2 Q26998829-57A7D91A-A5DB-4239-8B68-F1A8A7D3BA86 Q28083416-4199F6E9-E4E0-4687-B515-9476C36D0D6B Q28397511-E5EE96EF-0508-429D-93BE-612CC05C336A Q28487685-CFD88C3B-CA8A-413A-90F0-9DB30EB59CA1 Q33524885-F1061BE3-9CC4-4A7A-B341-58E9C4A58509 Q33713360-699B9A24-D1F6-40B9-B5A2-CE4AA0B74566 Q33757920-BC875475-959A-469A-9D7B-21084D81A55D Q33828465-9E3A30BB-42DF-4634-877A-636D2D8D5FC9 Q34046635-164BEF5A-EE83-4EA4-9A13-62B110F09823 Q34131233-FA09ADB2-B6AA-4580-845D-62DA9B173289 Q34134286-ED974711-D7E1-4525-AFBA-AD8390F46362 Q34191147-25A5D831-2E65-4F64-B8CF-FE9BD9FF34C5 Q34326427-93E7F3D6-7C22-4A55-82CC-3D0688DA1C7D Q34432435-6CF39334-D91B-46E2-A59B-959D94DE5109 Q34624313-8B6CB0E2-809F-49CB-BA99-8D4B52D8F813 Q35535488-D66D2FC8-4A77-47ED-AA1F-D674FC2567D6 Q35557419-8A70497B-153A-4C24-9867-C1B6B77B2893 Q35684900-1F470134-4315-4E15-84E2-AB5813D69B17 Q35782896-DEA09EBB-068F-4364-B222-01F8D999A551 Q35838456-6F6DA57C-3183-4E5E-BBC5-49CCF36447BC Q35919104-1FC20505-B84E-4407-ACAB-248106DE70D5 Q36207030-60F50720-A83C-4223-B737-F0DBFDEA90D4 Q36398938-737F1F1E-B94B-4088-99DA-7A0EB78E5692 Q36515910-54C2DE74-E0C8-4EF4-A702-DB3B9E88B6D0 Q36568302-697734CE-7C83-4CEB-946A-46E81C3F53D7 Q36644344-45CC0A55-737F-4227-A360-0A9642F52F7F Q36649713-2F7E48CC-AF43-4F86-A1B7-24E62A4AF53F Q36701411-EE714468-95A7-4799-9D3E-A12247703A57 Q37259282-AB0FFAE9-CB60-4FD1-B559-34F3680354FF Q37426263-39816E7B-A46E-41DB-94CC-86F3F106DA4B Q37577487-64AE3F69-AB1D-41E9-B534-E7008C23A824 Q37719732-B52B08BA-6E9C-41F8-87D4-A1642D00231D Q38033589-7B321926-6BD8-4B8F-8975-E075DCE0E571 Q38187226-0335B878-08D5-4204-95AA-813AF49DE9E0 Q38198637-0D0E2CCB-8164-47DD-AC48-097ADFD33572 Q38253491-FAD5B8AB-4627-43EA-9219-0C9787D862BF Q38274888-AE0B38ED-4C62-41A2-AC35-0580FAEAEB3A Q38280845-1B1A1ABB-7D5C-406F-B3E7-5836D47DD065

P2860

Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention.

http://www.wikidata.org/entity/Q33792231

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Novel approach to inhibit asth ...... using anti-CD147 intervention.

@ast

Novel approach to inhibit asth ...... using anti-CD147 intervention.

@en

type

label

Novel approach to inhibit asth ...... using anti-CD147 intervention.

@ast

Novel approach to inhibit asth ...... using anti-CD147 intervention.

@en

prefLabel

Novel approach to inhibit asth ...... using anti-CD147 intervention.

@ast

Novel approach to inhibit asth ...... using anti-CD147 intervention.

@en

P1433

Q33792231-2CC8EDF6-CFA2-46AF-9A5A-C3CF0DEA50E6

P1476

Q33792231-49569F37-87B5-4F9B-B7DB-A1CD314E7408

P2093

Q33792231-1BE2D9EA-1C40-4DF5-B059-50EB06110D59

Q33792231-3AD7E3F7-BD14-4638-9977-066BE2DE0DEC

Q33792231-56A787A4-700D-4E58-8F1B-B4E6A9E8BC67

Q33792231-79DF03E6-9407-4B89-8C90-A69B586FCBCE

Q33792231-809CEF72-C057-4935-A075-BFA463463FFE

Q33792231-81A3A899-167A-4CE7-8D4B-37680B62615E

Q33792231-8549212F-9F5F-45FC-9389-79AC5FAB4154

Q33792231-894A8129-CF31-4FA6-A980-92F5245755F7

Q33792231-898D4DE7-22F9-494C-B97A-9E840CA84987

Q33792231-994CA1F4-1A87-4858-BAA8-D400035E5DFD

P2860

Q33792231-02352DFD-5D9F-4584-8CB9-28BB45E004FE

Q33792231-0CE44184-AB42-4611-91D9-AEABC63F14ED

Q33792231-110B3F79-C3D8-4186-B348-091905CA4F6F

Q33792231-114BAD6E-A589-4BFB-A2D6-587779647132

Q33792231-15FF5321-5899-4FF3-AB81-FB7FC45ACF9C

Q33792231-1F0348D7-1839-41D2-B30F-096C8A11C650

Q33792231-1F891D0B-A36A-4792-8045-BA98EB4AB009

Q33792231-21254A4E-0701-41A7-A6CA-10E6088DEE8C

Q33792231-2CA7A562-1361-440C-9FD5-FA67041AAB35

Q33792231-2CB6969A-0326-436B-981E-301387EAE0AF

P304

Q33792231-6B549B0E-A045-4C07-8F87-E9AAF37933D1

P31

Q33792231-247F8081-A930-4361-A3A3-53B133734C35

P356

Q33792231-5640479E-7CF9-4635-89F1-6C528A892FFB

P407

Q33792231-FC4F736E-66AA-48AF-BAC5-074A2BDF56E2

P433

Q33792231-7DBDCC11-2296-43E6-84C0-E2EA7F2463A6

P478

Q33792231-7A0E1B5E-26BB-4C63-AE8C-D053E7E31B9B

P577

Q33792231-FC89B735-1BBB-4030-8FBF-52D92EE9C600

P5875

Q33792231-CA8A9850-B6D8-4795-8631-7ADB4C13BED1

P698

Q33792231-A51D3CE8-E7C9-482D-ACE3-5D92090B88BA

P921

Q33792231-5F794E7E-961B-4EE3-9A0E-FEF918BE7EB8

Q33792231-84F45329-F07F-4B8C-AF16-AC640655AAF3

P932

Q33792231-07183721-2D32-4648-80A3-0CC2CA494520

P356

JIMMUNOL.177.7.4870

P1433

Journal of Immunology

P1476

Novel approach to inhibit asth ...... using anti-CD147 intervention.

@en

P2093

Achsah D Keegan

http://www.w3.org/2001/XMLSchema#string

Ann Kelly-Welch

http://www.w3.org/2001/XMLSchema#string

Christophe Vanpouille

http://www.w3.org/2001/XMLSchema#string

David Leitenberg

http://www.w3.org/2001/XMLSchema#string

Ifeanyi Okwumabua

http://www.w3.org/2001/XMLSchema#string

James J Lee

http://www.w3.org/2001/XMLSchema#string

Jesse M Damsker

http://www.w3.org/2001/XMLSchema#string

Lindsay A Dent

http://www.w3.org/2001/XMLSchema#string

Michael I Bukrinsky

http://www.w3.org/2001/XMLSchema#string

Rustom Falahati

http://www.w3.org/2001/XMLSchema#string

P2860

CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression

Dealing with the family: CD147 interactions with cyclophilins

Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.

The cyclophilins

Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70)

CD147 is a signaling receptor for cyclophilin B

Active site residues of cyclophilin A are crucial for its signaling activity via CD147

Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule

Interleukin-13: central mediator of allergic asthma

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

P304

4870-4879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.177.7.4870

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6811276

http://www.w3.org/2001/XMLSchema#string

P698

16982929

http://www.w3.org/2001/XMLSchema#string

P921

P932

2855298

http://www.w3.org/2001/XMLSchema#string